Insightec Announces Seoul National University Hospital to Install Exablate Neuro Platform


Expanding patient access to non-incisional focused ultrasound treatment

HAIFA, Israel and MIAMI, August 9, 2021 / PRNewswire / – Insightec®, a global healthcare company focused on creating the next generation of patient care, Seoul announced National university The hospital installs the company’s Exablate® Neuro platform. The Exablate Neuro (Exablate 4000) platform uses focused ultrasound to ablate targets deep within the brain for therapeutic effect.

“This is the first installation of our first focused ultrasound technology on the market in a public hospital in South Korea“commented Ori Atar, director of Asian growth markets at Insightec.” It’s exciting to know that more patients will now have access to an incision-free treatment option. “

“Focused ultrasound provides a precision tool for neurosurgical treatments,” said Pr. Kim Seung Ki, explains the head of SNUH neurosurgery. “Clinical evidence has demonstrated a positive impact on the quality of life of patients with a favorable safety profile.”

There are 81 leading medical centers around the world that have implemented Focused Ultrasound programs with Exablate Neuro. Insightec partners with Huons, a pharmaceutical manufacturer and distributor of medical solutions, to bring focused ultrasound to Korean healthcare systems.

“Bringing cutting-edge technology that improves people’s health to the world’s largest public hospital is an important step,” said Key-An Um, CEO of Huons. “Medical centers are realizing the value that a focused ultrasound program can bring to patient care.”

Insightec media contact
G&S Commercial Communications for Insightec
Elizabeth mannheimer
+1 917.595.3034
[email protected]


SOURCE Insightec


Comments are closed.